Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger

We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. Akero Therapeutics, Inc. (NASDAQ:AKRO) is one of the best performers on Thursday. Akero Therapeutics saw its share prices jump by 16.33 percent on Thursday to end at $54.08 apiece following announcements that it was set to merge with Novo Nordisk in a $5.2 billion deal. In a statement, Akero Therapeutics, Inc. (NASDAQ:AKRO) said both companies officially entered into a definitive agreement, under which Novo Nordisk would acqui ...